Si-Chang Qu1, Ding Xu1, Ting-Ting Li1, Jing-Fa Zhang2, Fang Liu1. 1. Department of Ophthalmology of Shanghai Tenth People's Hospital, Tongji Eye Institute, Tongji University School of Medicine, Shanghai 200072, China. 2. Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University, Shanghai 200080, China.
Abstract
AIM: To preliminarily test proteomics in aqueous humor in patients with dry age-related macular degeneration (AMD) by using the proteomic technology. METHODS: Aqueous humor samples were collected from patients with or without dry AMD, who underwent cataract surgery. The aqueous samples were analyzed with isobaric tags for relative and absolute quantification (iTRAQ) combined with liquid chromatography tandem mass spectrometry (LC-MS/MS) technology. The differential expressed proteins were analyzed with gene ontology (GO) enrichment, Kyoto Encyclopedia of Genes and Genomes (KEGG) and protein-protein interaction (PPI) network analysis. The data were partly validated by ELISA and Western blot. False discovery rate (FDR) was used for statistical analysis. RESULTS: A total of 244 proteins were detected, in which 38 proteins were up-regulated and 51 were down-regulated significantly in patients with dry AMD compared with that in control groups (FDR value <1.0%). Several proteins, e.g., protein S100-A8 (S10A8), dystroglycan (DAG1), Ig alpha-1 chain C region (IGHA1), carbonic anhydrase 3 (CAH3) and alpha-1-acid glycoprotein (A1AG1) were increased more than 5 times of that in control group. The bioinformatics analysis showed that dry AMD is closely associated with inflammation or immune reaction, oxidative stress, blood coagulation and remodeling of extracellular matrix. CONCLUSION: iTRAQ-based proteomic analysis of aqueous humor demonstrate the differential expressions of proteins between dry AMD and control groups, providing the clues to understand the mechanisms and possible treatments of dry AMD. International Journal of Ophthalmology Press.
AIM: To preliminarily test proteomics in aqueous humor in patients with dry age-related macular degeneration (AMD) by using the proteomic technology. METHODS: Aqueous humor samples were collected from patients with or without dry AMD, who underwent cataract surgery. The aqueous samples were analyzed with isobaric tags for relative and absolute quantification (iTRAQ) combined with liquid chromatography tandem mass spectrometry (LC-MS/MS) technology. The differential expressed proteins were analyzed with gene ontology (GO) enrichment, Kyoto Encyclopedia of Genes and Genomes (KEGG) and protein-protein interaction (PPI) network analysis. The data were partly validated by ELISA and Western blot. False discovery rate (FDR) was used for statistical analysis. RESULTS: A total of 244 proteins were detected, in which 38 proteins were up-regulated and 51 were down-regulated significantly in patients with dry AMD compared with that in control groups (FDR value <1.0%). Several proteins, e.g., protein S100-A8 (S10A8), dystroglycan (DAG1), Ig alpha-1 chain C region (IGHA1), carbonic anhydrase 3 (CAH3) and alpha-1-acid glycoprotein (A1AG1) were increased more than 5 times of that in control group. The bioinformatics analysis showed that dry AMD is closely associated with inflammation or immune reaction, oxidative stress, blood coagulation and remodeling of extracellular matrix. CONCLUSION: iTRAQ-based proteomic analysis of aqueous humor demonstrate the differential expressions of proteins between dry AMD and control groups, providing the clues to understand the mechanisms and possible treatments of dry AMD. International Journal of Ophthalmology Press.
Entities:
Keywords:
age-related macular degeneration; aqueous humor; differential expression of proteins; isobaric tags for relative and absolute quantification; protein biomarker
Authors: M Ashburner; C A Ball; J A Blake; D Botstein; H Butler; J M Cherry; A P Davis; K Dolinski; S S Dwight; J T Eppig; M A Harris; D P Hill; L Issel-Tarver; A Kasarskis; S Lewis; J C Matese; J E Richardson; M Ringwald; G M Rubin; G Sherlock Journal: Nat Genet Date: 2000-05 Impact factor: 38.330
Authors: Eveline Kersten; Constantin C Paun; Rosa L Schellevis; Carel B Hoyng; Cécile Delcourt; Imre Lengyel; Tunde Peto; Marius Ueffing; Caroline C W Klaver; Sascha Dammeier; Anneke I den Hollander; Eiko K de Jong Journal: Surv Ophthalmol Date: 2017-05-15 Impact factor: 6.048
Authors: Tae Wan Kim; Jeong Won Kang; Jeeyun Ahn; Eun Kyung Lee; Kyung-Cho Cho; Bit Na Ra Han; Nam Young Hong; Jisook Park; Kwang Pyo Kim Journal: J Proteome Res Date: 2012-07-13 Impact factor: 4.466
Authors: Xianglin Yuan; Xiaorong Gu; John S Crabb; Xiuzhen Yue; Karen Shadrach; Joe G Hollyfield; John W Crabb Journal: Mol Cell Proteomics Date: 2010-02-22 Impact factor: 5.911
Authors: John R W Yates; Tiina Sepp; Baljinder K Matharu; Jane C Khan; Deborah A Thurlby; Humma Shahid; David G Clayton; Caroline Hayward; Joanne Morgan; Alan F Wright; Ana Maria Armbrecht; Baljean Dhillon; Ian J Deary; Elizabeth Redmond; Alan C Bird; Anthony T Moore Journal: N Engl J Med Date: 2007-07-18 Impact factor: 91.245
Authors: Bruno Nobre Lins Coronado; Felipe Bruno Santos da Cunha; Otávio de Toledo Nobrega; Aline Maria Araujo Martins Journal: Int Ophthalmol Date: 2021-04-02 Impact factor: 2.031
Authors: Yingda Jiang; Chi-Yang Chiu; Qi Yan; Wei Chen; Michael B Gorin; Yvette P Conley; M'Hamed Lajmi Lakhal-Chaieb; Richard J Cook; Christopher I Amos; Alexander F Wilson; Joan E Bailey-Wilson; Francis J McMahon; Ana I Vazquez; Ao Yuan; Xiaogang Zhong; Momiao Xiong; Daniel E Weeks; Ruzong Fan Journal: J Am Stat Assoc Date: 2020-07-28 Impact factor: 5.033